Arca
Skip to content

Vicryo* (Polyglactin 910) Braided Coated And Uncoated Synthetic Absorbable Suture, Dyed & Undyed, Braided And Monofilamt

Suture, Absorbable, Synthetic, Polyglycolic Acid. 510(k) K946271, from ETHICON, Inc. (Somerville, NJ). Product code GAM, class 2.

As of Nov 17, 2026, K946271 is an FDA 510(k) held by ETHICON, Inc., substantially equivalent on Jun 15, 1995 after 174 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Jun 15, 1995
  • Review time: 174 days
  • Recalls: 1
  • Cited as a predicate by: 3 devices

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K946271, newest first; each opens FDA's recall record
StartedReasonStatus
Feb 2, 2009Z-1309-2009Sterility Issue: The firm decided to remove the product because it cannot assure the sterility of the products due to a failure in the sterilization process.Terminated

Other GAM Clearances

The newest 510(k)s for the same product code; their median review was 116 days; see every GAM device

Record

Type
Traditional
Received
Dec 23, 1994
Review panel
General, Plastic Surgery
Regulation
21 CFR 878.4493

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.